Literature DB >> 20802992

[Evidence-based therapy of depression: S3 guidelines on unipolar depression].

M Härter1, C Klesse, I Bermejo, T Bschor, J Gensichen, T Harfst, M Hautzinger, C Kolada, I Kopp, C Kühner, M Lelgemann, J Matzat, B Meyerrose, C Mundt, W Niebling, G Ollenschläger, R Richter, H Schauenburg, H Schulz, S Weinbrenner, F Schneider, M Berger.   

Abstract

Unipolar depressive disorders are among the most frequent reasons for utilizing the health care system. Although efficacious treatments are available and further advances have recently been made there is still a need for improving diagnostic and therapeutic procedures. Alignment of treatment on evidence-based treatment guidelines establishes an essential mainstay. The new S3 and National Health Care guidelines on unipolar depression, the compilation of which was coordinated by the German Society of Psychiatry, Psychotherapy and Neurology (DGPPN) and which were approved by 29 scientific and professional associations, is the ambitious effort to present state of the art evidence and clinical consensus for the treatment of depression. For pharmacotherapy of depression differentiated recommendations can be given, also separate from and in addition to psychotherapy.

Entities:  

Mesh:

Year:  2010        PMID: 20802992     DOI: 10.1007/s00115-010-3084-7

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  44 in total

1.  Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

Authors:  I M Anderson
Journal:  J Affect Disord       Date:  2000-04       Impact factor: 4.839

2.  Clinical guidelines for the treatment of depressive disorders.

Authors: 
Journal:  Can J Psychiatry       Date:  2001-06       Impact factor: 4.356

Review 3.  Antidepressant versus placebo for depressed elderly.

Authors:  K Wilson; P Mottram; A Sivanranthan; A Nightingale
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 4.  [Analysis and evaluation of current guidelines for diagnosis and treatment of depressive disorders:].

Authors:  M Härter; I Bermejo; A Aschenbrenner; M Berger
Journal:  Fortschr Neurol Psychiatr       Date:  2001-09       Impact factor: 0.752

5.  Improving quality of care for depression: the German Action Programme for the implementation of evidence-based guidelines.

Authors:  Martin Härter; Isaac Bermejo; Günter Ollenschläger; Frank Schneider; Wolfgang Gaebel; Ulrich Hegerl; Wilhelm Niebling; Mathias Berger
Journal:  Int J Qual Health Care       Date:  2005-10-31       Impact factor: 2.038

Review 6.  Antidepressant drug effects and depression severity: a patient-level meta-analysis.

Authors:  Jay C Fournier; Robert J DeRubeis; Steven D Hollon; Sona Dimidjian; Jay D Amsterdam; Richard C Shelton; Jan Fawcett
Journal:  JAMA       Date:  2010-01-06       Impact factor: 56.272

7.  Psychotherapy for chronic major depression and dysthymia: a meta-analysis.

Authors:  Pim Cuijpers; Annemieke van Straten; Josien Schuurmans; Patricia van Oppen; Steven D Hollon; Gerhard Andersson
Journal:  Clin Psychol Rev       Date:  2010-02

Review 8.  [Affective disorders. The significance of psychotherapeutic approaches].

Authors:  M Berger; E L Brakemeier; C Klesse; E Schramm
Journal:  Nervenarzt       Date:  2009-05       Impact factor: 1.214

Review 9.  Combined pharmacotherapy and psychological treatment for depression: a systematic review.

Authors:  Sandro Pampallona; Paola Bollini; Giuseppe Tibaldi; Bruce Kupelnick; Carmine Munizza
Journal:  Arch Gen Psychiatry       Date:  2004-07

10.  Selective publication of antidepressant trials and its influence on apparent efficacy.

Authors:  Erick H Turner; Annette M Matthews; Eftihia Linardatos; Robert A Tell; Robert Rosenthal
Journal:  N Engl J Med       Date:  2008-01-17       Impact factor: 91.245

View more
  8 in total

1.  [A new evidence and consensus-based German guidelines for diagnosis and treatment of bipolar disorders].

Authors:  M Bauer
Journal:  Nervenarzt       Date:  2012-05       Impact factor: 1.214

Review 2.  Depressive syndromes in neurological disorders.

Authors:  Julian Hellmann-Regen; Dominique Piber; Kim Hinkelmann; Stefan M Gold; Christoph Heesen; Carsten Spitzer; Matthias Endres; Christian Otte
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-11       Impact factor: 5.270

Review 3.  [Depression and neurological diseases].

Authors:  D Piber; K Hinkelmann; S M Gold; C Heesen; C Spitzer; M Endres; C Otte
Journal:  Nervenarzt       Date:  2012-11       Impact factor: 1.214

4.  Combination of agomelatine and bupropion for treatment-resistant depression: results from a chart review study including a matched control group.

Authors:  Kurt-Wolfram Sühs; Christoph Correll; Christian K Eberlein; Refik Pul; Helge Frieling; Stefan Bleich; Kai G Kahl
Journal:  Brain Behav       Date:  2015-02-19       Impact factor: 2.708

5.  Depression, Comorbidities, and Prescriptions of Antidepressants in a German Network of GPs and Specialists with Subspecialisation in Anthroposophic Medicine: A Longitudinal Observational Study.

Authors:  Elke Jeschke; Thomas Ostermann; Horst C Vollmar; Manuela Tabali; Harald Matthes
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-06       Impact factor: 2.629

6.  CAM in Psychiatry.

Authors:  Jörg Melzer; Hans-Christian Deter; Bernhard Uehleke
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-25       Impact factor: 2.629

7.  Insular and hippocampal gray matter volume reductions in patients with major depressive disorder.

Authors:  Mirjam Stratmann; Carsten Konrad; Harald Kugel; Axel Krug; Sonja Schöning; Patricia Ohrmann; Christina Uhlmann; Christian Postert; Thomas Suslow; Walter Heindel; Volker Arolt; Tilo Kircher; Udo Dannlowski
Journal:  PLoS One       Date:  2014-07-22       Impact factor: 3.240

8.  Adherence to Established Treatment Guidelines Among Unguided Digital Interventions for Depression: Quality Evaluation of 28 Web-Based Programs and Mobile Apps.

Authors:  Stefan Bubolz; Gwendolyn Mayer; Nadine Gronewold; Thomas Hilbel; Jobst-Hendrik Schultz
Journal:  J Med Internet Res       Date:  2020-07-13       Impact factor: 5.428

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.